| Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer TMA Abdel-Fatah, R Russell, N Albarakati, DJ Maloney, D Dorjsuren, ... Molecular oncology 8 (7), 1326-1338, 2014 | 129 | 2014 |
| Targeting XRCC1 deficiency in breast cancer for personalized therapy R Sultana, T Abdel-Fatah, R Abbotts, C Hawkes, N Albarakati, ... Cancer research 73 (5), 1621-1634, 2013 | 111 | 2013 |
| Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells R Sultana, T Abdel-Fatah, C Perry, P Moseley, N Albarakti, V Mohan, ... PloS one 8 (2), e57098, 2013 | 102 | 2013 |
| Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy N Albarakati, TMA Abdel-Fatah, R Doherty, R Russell, D Agarwal, ... Molecular oncology 9 (1), 204-217, 2015 | 86 | 2015 |
| KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer AT Alshareeda, OH Negm, AR Green, CC Nolan, P Tighe, N Albarakati, ... British journal of cancer 112 (12), 1929-1937, 2015 | 78 | 2015 |
| Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer AT Alshareeda, OH Negm, N Albarakati, AR Green, C Nolan, R Sultana, ... Breast cancer research and treatment 139, 301-310, 2013 | 73 | 2013 |
| Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy TMA Abdel-Fatah, N Albarakati, L Bowell, D Agarwal, P Moseley, ... Breast cancer research and treatment 142, 515-527, 2013 | 42 | 2013 |
| DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts TMA Abdel-Fatah, R Russell, D Agarwal, P Moseley, MA Abayomi, ... Molecular Oncology 8 (3), 520-532, 2014 | 38 | 2014 |
| SUMOylation proteins in breast cancer AT Alshareeda, OH Negm, AR Green, C Nolan, P Tighe, N Albarakati, ... Breast cancer research and treatment 144, 519-530, 2014 | 38 | 2014 |
| Circulating proteomic signature for detection of biomarkers in bladder cancer patients T Nedjadi, H Benabdelkamal, N Albarakati, A Masood, A Al-Sayyad, ... Scientific reports 10 (1), 10999, 2020 | 33 | 2020 |
| The prognostic impact of GSTM1/GSTP1 genetic variants in bladder cancer N Albarakati, D Khayyat, A Dallol, J Al-Maghrabi, T Nedjadi BMC cancer 19, 1-11, 2019 | 13 | 2019 |
| Proteomic profiling of plasma-derived biomarkers in patients with bladder cancer: a step towards clinical translation T Nedjadi, N Albarakati, H Benabdelkamel, A Masood, AA Alfadda, ... Life 11 (12), 1294, 2021 | 9 | 2021 |
| Interaction between HER2 and ATM predicts poor survival in bladder cancer patients N Albarakati, A Al‐Shareeda, M Ramadan, B Al‐Sowayan, O Negm, ... Journal of Cellular and Molecular Medicine 26 (19), 4959-4973, 2022 | 2 | 2022 |
| Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients N Albarakati, H Al-Ghamdi, B Al-Sowayan, A Alshareeda Scientific Reports 13 (1), 11738, 2023 | 1 | 2023 |
| 275 targeting XRCC1 (X-ray repair cross-complementing gene 1), a key DNA base excision repair protein for personalized therapy in breast and ovarian cancer R Sultana, T Abdel-Fatah, N Albarakati, R Abbotts, C Seedhouse, G Ball, ... European Journal of Cancer, 85, 2012 | 1 | 2012 |
| Targeting Ataxia telangiectasia mutated (ATM) and DNA dependent protein kinase catalytic subunit (DNA-PKcs) for synthetic lethality application in breast cancer N Albarakati University of Nottingham, 2015 | | 2015 |
| Assessment of DNA-damage repair in breast cancer A Alshareeda University of Nottingham, 2014 | | 2014 |
| DNA polymerase? deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts T Abdel-Fatah, R Russell, D Agarwal, P Moseley, MA Abayomi, C Perry, ... Molecular Oncology 8 (3), 2014 | | 2014 |
| Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is R Sultana, T Abdel-Fatah, C Perry, P Moseley, N Albarakti | | 2013 |
| Hidden Regulators: The Emerging Roles of LncRNAs in Brain Development and Disease F Alammari, E Al-hujaily, A Alshareeda, N Albarakati, BS Al-Sowayan Frontiers in Neuroscience 18, 1392688, 0 | | |
